1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Aggressive pituitary tumors and pituitary carcinomas : from pathology to treatment
(
- Contribution to journal › Article
-
Mark
Initial pathology in aggressive pituitary tumours and carcinomas : 2b or not 2b?-that is the question
(
- Contribution to journal › Article
- 2022
-
Mark
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
(
- Contribution to journal › Article
- 2018
-
Mark
Treatment of aggressive pituitary tumours and carcinomas : results of a European Society of Endocrinology (ESE) survey 2016
(
- Contribution to journal › Article
-
Mark
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
(
- Contribution to journal › Article
-
Mark
CM-Score : A validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe
(
- Contribution to journal › Article
- 2017
-
Mark
A permissive role of growth hormone (GH) in the development of second brain tumors after radiotherapy?
(
- Contribution to journal › Letter
- 2015
-
Mark
ESE guidelines, why and how.
(
- Contribution to journal › Debate/Note/Editorial
- 2010
-
Mark
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis.
(
- Contribution to journal › Article